Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease
- Substances:Golimumab
Poland- Participants:18–64 years · 65+ years
- Substances:Golimumab
- Sponsor:Janssen Cilag International
Rare diseases
Investigational molecules
Locations
Ul. Lwowska 34, 41-500 Chorzow, Poland
M2m Med. Sp. z o.o. in Chorzow, Poland specialises in clinical trials of conditions such as Crohn's disease, Dementia Alzheimer's type, Myelofibrosis, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.
The site’s work centers on psychiatry and psychology with an emphasis on behavior mechanisms. Researchers are studying electronic cigarette cessation, evaluating whether cytisine combined with behavioral counseling can improve quit rates. The aim is to determine the effectiveness of this combined approach compared with placebo.
Located in Chorzow, Poland, M2m Med. Sp. z o.o. operates as a commercial laboratory and has launched two investigator‑led trials with a team of eight researchers.
Clinical trials currently enrolling participants at this site.
PolandStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
PolandA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
PolandA study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer's disease
PolandStudy of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy
PolandStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
PolandA Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis
PolandA study to test if tibulizumab works and is safe for adults with systemic sclerosis
PolandStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
PolandStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
PolandSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
PolandStudy of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.